Skip to main contentSign up for our newsletter

About the LONDC

Sitting at the intersection of research, clinical care, patient advocacy, and industry innovation, the American Neuromuscular Foundation (ANF) observed a need to better serve those living with late-onset neuromuscular diseases (LONDs) by bringing the community together and fostering collaboration to improve care, education, and quality of life. This is the rationale for establishing the Late-Onset Neuromuscular Disease Consortium (LONDC).

The LONDC is designed to drive progress by:

Four hands in a circle icon

Identifying common challenges, needs, and opportunities across conditions

Hierarchy showing 1 person with lines to 3 people icon

Facilitating collaboration among multiple stakeholders

Globe with 3 people in front icon

Establishing community-wide goals and strategies

1 person presenting to 3 people icon

Providing a forum to share updates and progress

3 people sitting at a table icon

Supplementing work underway by community stakeholders

During the LONDC’s inaugural meeting, participants identified key gaps contributing to delays in diagnosing LONDs and prioritized potential areas of focus. Based on this input, the LONDC Steering Committee selected a project aimed at improving early recognition and awareness of LONDs to help shorten the diagnostic journey for patients and support clinicians in making timely referrals.

Improving Recognition and Referral of Late-Onset Neuromuscular Diseases

The LONDC has launched two key resources to help reduce delays in diagnosing LONDs:

LOND Clinical Decision Tool

Developed through patient and physician research, a series of workshops and focus groups, and a consensus process with neuromuscular specialists from both neurology and physical medicine rehabilitation, this tool assists first-line healthcare providers in identifying potential LOND symptoms earlier and guiding appropriate referrals.

“Why Behind Your Weakness” Campaign

This campaign and its accompanying website, WhyBehindWeakness.org, aim to help individuals recognize symptoms, seek guidance, and engage in earlier conversations with their healthcare providers.

Together, these resources reflect the LONDC’s commitment to improving recognition, referral pathways, and support for those affected by LONDs. More background on the work leading to this launch can be found in our 2025 progress report, available here.

LONDC News

Mar. 9, 2026
LONDC Launches Clinical Tool and Consumer Awareness Campaign
Jan. 10, 2025
Initial Consensus Discussion Yields Positive Momentum

Steering Committee

The LONDC Steering Committee consists of representatives from advocacy organizations that serve people impacted by neuromuscular conditions. Steering Committee members provide ongoing strategic direction, advocate for the LONDC and its initiatives, and oversee and drive projects forward in alignment with the Steering Committee governance.

Current Members

If you are part of an advocacy organization and are interested in becoming a Steering Committee member, complete the interest form here.

The following conditions, which typically manifest in adulthood and will be targeted by the LONDC and its initiatives, include:

  • Acute Inflammatory Demyelinating Polyradiculopathy (AIDP, Guillain-Barré)
  • Adult spinal muscular atrophy (SMA)
  • Amyotrophic lateral sclerosis (ALS)
  • Becker muscular dystrophy (BMD)
  • Charcot-Marie-Tooth (CMT)
  • Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)
  • Congenital muscular dystrophy (CMD)
  • Facioscapulohumeral muscular dystrophy (FSHD)
  • GNE myopathy
  • Hereditary transthyretin amyloidosis (hATTR)
  • Inclusion body myositis (IBM)
  • Lambert-Eaton myasthenic syndrome (LEMS)
  • Late-onset Pompe disease (LOPD)
  • Limb-girdle muscular dystrophy (LGMD)
  • Multifocal motor neuropathy (MMN)
  • Myasthenia gravis (MG)
  • Myotonic dystrophy (DM) types 1 and 2
  • Oculopharyngeal muscular dystrophy (OPMD)
  • Spinal and bulbar muscular atrophy (SBMA, Kennedy’s Disease)
  • VCP Disease
Thank you to our sponsors for supporting the LONDC and its initiatives!

2025 Grand Champion

Champion

Contributors

Supporter

Friend

Thank you to the American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) for providing support for the LONDC administrative fees.

How can my organization get involved with the LONDC?

Contact us for sponsorship opportunities or to learn how your organization can participate in collaborative efforts to address unmet needs of individuals affected by late-onset neuromuscular diseases. Individuals can also help fund the ANF and LONDC by donating here.